Key Record Dates
ClinicalTrials.gov Identifier: | NCT04512235 |
---|---|
Brief Title: | A Study to Evaluate the Efficacy and Safety of CAEL-101 in Patients With Mayo Stage IIIa AL Amyloidosis |
First Submitted : | August 10, 2020 |
First Submitted that Met QC Criteria : | August 12, 2020 |
First Posted : | August 13, 2020 |
Last Update Submitted that Met QC Criteria : | May 22, 2023 |
Last Update Posted : | May 23, 2023 |